These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4063950)

  • 1. Dosage predictions in high-dose methotrexate infusions. Part 2: Bayesian estimation of methotrexate clearance.
    Bruno R; Iliadis A; Favre R; Lena N; Imbert AM; Cano JP
    Cancer Drug Deliv; 1985; 2(4):277-83. PubMed ID: 4063950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage predictions in high-dose methotrexate infusions. Part 1: Evaluation of the classic test-dose protocol.
    Cano JP; Bruno R; Lena N; Favre R; Iliadis A; Imbert AM
    Cancer Drug Deliv; 1985; 2(4):271-6. PubMed ID: 3864520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.
    Iven H; Brasch H; Engster J
    Cancer Chemother Pharmacol; 1985; 15(2):115-20. PubMed ID: 4017160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian estimation and prediction of clearance in high-dose methotrexate infusions.
    Iliadis A; Bachir-Raho M; Bruno R; Favre R
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):101-15. PubMed ID: 3839529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and toxicity of frequent intermediate dose methotrexate infusions.
    Parker RI; Forman EN; Krumm KF; Abeel MJ; Martin HF
    Ther Drug Monit; 1986; 8(4):393-9. PubMed ID: 3469802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach.
    Odoul F; Le Guellec C; Lamagnère JP; Breilh D; Saux MC; Paintaud G; Autret-Leca E
    Fundam Clin Pharmacol; 1999; 13(5):595-604. PubMed ID: 10520733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses.
    Luyckx M; Cazin JL; Brunet C; Gosselin P; Demaille MC
    Eur J Clin Pharmacol; 1985; 28(4):457-62. PubMed ID: 3839754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer.
    Monjanel-Mouterde S; Lejeune C; Ciccolini J; Merite N; Hadjaj D; Bonnier P; Piana P; Durand A
    J Clin Pharm Ther; 2002 Jun; 27(3):189-95. PubMed ID: 12081632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapy.
    Slørdal L; Kolmannskog S; Prytz PS; Moe PJ; Aarbakke J
    Pediatr Hematol Oncol; 1986; 3(2):127-34. PubMed ID: 3153222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
    Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R
    Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage adjustment of high-dose methotrexate using Bayesian estimation: a comparative study of two different concentrations at the end of 8-h infusions.
    Pignon T; Lacarelle B; Duffaud F; Guillet P; Catalin J; Durand A; Favre R
    Ther Drug Monit; 1995 Oct; 17(5):471-8. PubMed ID: 8585110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia.
    Evans WE; Stewart CF; Hutson PR; Cairnes DA; Bowman WP; Yee GC; Crom WR
    Drug Intell Clin Pharm; 1982 Nov; 16(11):839-42. PubMed ID: 6959800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of non-renal elimination mechanisms of methotrexate (MTX)].
    Erttmann R; Gkanatsas A
    Monatsschr Kinderheilkd; 1985 Aug; 133(8):516-9. PubMed ID: 3876505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
    Fernández Megía MJ; Alós Almiñana M; Esquer Borrás J
    Farm Hosp; 2004; 28(6):433-9. PubMed ID: 15628946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.